Patent details
EP4049681 Title: PHARMACEUTICAL COMPOSITIONS COMPRISING AN ANTIPSYCHOTIC DRUG AND A VMAT2 INHIBITOR AND USES THEREOF
Basic Information
- Publication number:
- EP4049681
- PCT Application Number:
- Type:
- European Patent Granted for LU
- Legal Status:
- Unitary Effect Registered
- Application number:
- EP212164099
- PCT Publication Number:
- First applicant's nationality:
- Translation Language:
- EPO Publication Language:
- English
- English Title of Invention:
- PHARMACEUTICAL COMPOSITIONS COMPRISING AN ANTIPSYCHOTIC DRUG AND A VMAT2 INHIBITOR AND USES THEREOF
- French Title of Invention:
- COMPOSITIONS PHARMACEUTIQUES COMPRENANT UN MÉDICAMENT ANTIPSYCHOTIQUE ET UN INHIBITEUR DE VMAT2 ET LEURS UTILISATIONS
- German Title of Invention:
- PHARMAZEUTISCHE ZUSAMMENSETZUNGEN MIT ANTIPSYCHOTIKA UND VMAT2-INHIBITOR SOWIE VERWENDUNGEN DAVON
- SPC Number:
Unitary Effect
- Unitary Effect Requested:
- Yes
- Unitary Effect Request Filing Date:
- 14/01/2026
- Link to UPP Register:
- European Patent Register
- Unitary Effect Request Withdrawal Date:
- Unitary Effect Status:
- Unitary Effect Registered
- Unitary Effect Acceptance Decision Date:
- 20/01/2026
- Unitary Effect Rejection Decision Date:
- Unitary Effect Date:
- 07/01/2026
- Unitary Effect Registration Date:
- 20/01/2026
- Unitary Effect Re-establishment of rights Filing Date:
- Unitary Effect Re-establishment of rights EPO Decision :
- Unitary Effect Re-establishment of rights EPO Decision Date:
- Explanatory Text UE:
- Safety Net Request Date:
- Safety Net Decision Date:
- Safety Net Decision Outcome:
- SPC Number:
Dates
- Filing date:
- 06/02/2015
- Grant date:
- 07/01/2026
- EP Publication Date:
- 31/08/2022
- PCT Publication Date:
- Claims Translation Received Date:
- Translations Received Date (B1 EP Publication):
- Translations Received Date (B2 EP Publication):
- Translations Received Date (B3 EP Publication):
- Publication date:
- 07/01/2026
- EP B1 Publication Date:
- 07/01/2026
- EP B2 Publication Date:
- EP B3 Publication Date:
- Lapsed date:
- Expiration date:
- 06/02/2035
- Renunciation date:
- Revocation date:
- Annulment date:
Owner
- From:
- 31/12/2025
- Name:
- Neurocrine Biosciences, Inc.
- Address:
- 6027 Edgewood Bend Court, San Diego, CA 92130, United States (US)
Inventor
- Name:
- HOARE, Samuel Roger Jesse
- Address:
- United States (US)
Priority
- Priority Number:
- 201461937223 P
- Priority Date:
- 07/02/2014
- Priority Country:
- United States (US)
Classification
- IPC classification:
- A61K 31/473; A61K 45/06; A61P 43/00; A61P 25/24; A61P 25/18; A61K 31/5513; A61K 31/551; A61K 31/519; A61K 31/4745;
Publication
European Patent Bulletin
1
- Issue number:
- 202602
- Publication date:
- 07/01/2026
- Description:
- Grant (B1)
2
- Issue number:
- 202608
- Publication date:
- 18/02/2026
- Description:
- Unitary Effect Request Receipt
3
- Issue number:
- 202608
- Publication date:
- 18/02/2026
- Description:
- Unitary Effect Request Acceptance
Annual Fees
- Annual Fee Due Date:
- Annual Fee Number:
- Expected Payer:
- Last Annual Fee Payment Date:
- Last Annual Fee Paid Number:
- Payer:
| Filing date | Document type | Number of pages |
|---|